STX4 and cancer: In cancer cells and islet β-cells, STX4 has a putative phosphorylation site at Ser78, which when mutated to Ser78Ala, results in STX4 protein stabilization (171, 172) Given the pivotal importance of STX4 in skeletal muscle glucose uptake, capitalizing on this stabilizing mutation could harbor therapeutic potential.